Literature DB >> 7367642

Serendipity in technetium-99m dimethyl iminodiacetic acid cholescintigraphy: diagnosis of nonbiliary disorders in suspected acute cholecystitis.

H S Weissmann, L A Sugarman, M S Frank, L M Freeman.   

Abstract

Technetium-99m dimethyl iminodiacetic acid cholescintigraphy has contributed significantly to the diagnosis of acute and chronic biliary tract disorders. Yet attention should also be focused on the other structures visualized during the blood pool, hepatocyte, renal excretory, and intestinal phases of the study. Nonbiliary pathology was detected in 42 of 294 patients (14.3%) studied for suspected acute cholecystitis. The serendipitous detection of previously unsuspected abnormalities assisted in directing further work-up from suspected biliary disease and towards the real source of the patient's acute problem in 28 cases (9.5%).

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367642     DOI: 10.1148/radiology.135.2.7367642

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Diagnosis of acute cholecystitis with 99mTc-IDA cholescintigraphy.

Authors:  H S Weissmann; L A Sugarman; L M Freedman
Journal:  Bull N Y Acad Med       Date:  1981-11

2.  Combined common bile duct and gastric outlet obstruction demonstrated during hepatobiliary scintigraphy.

Authors:  A J Moreno; A L Parker; A A Rodriguez; K A Sorensen; G L Turnbull
Journal:  Eur J Nucl Med       Date:  1985

3.  Acute pancreatitis: secondary findings on hepatobiliary scintigraphy.

Authors:  M Kupfer; P Colletti; P Ralls
Journal:  Eur J Nucl Med       Date:  1988

4.  Characteristic cholescintigraphic images in space-occupying lesions.

Authors:  F Scopinaro; F Iorio; M Flammia; M Scarpini
Journal:  Eur J Nucl Med       Date:  1982

5.  Concurrent detection of cholecystocolic fistula and hepatic abscess by hepatobiliary scintigraphy.

Authors:  H Seto; N Watanabe; M Kageyama; M Shimizu; T Nagayoshi; Y Kamisaki; M Kakishita
Journal:  Ann Nucl Med       Date:  1995-05       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.